Lupin has completed the acquisition of 42.61% of the equity share capital of Sunsure Solarpark Seventeen (Sunsure Solarpark) and successfully completed the Transaction. The company has completed the acquisition on January 9, 2025.
Earlier, the company had signed Share Subscription & Shareholders agreement with Sunsure Solarpark and Sunsure Energy (Sunsure) to make equity investment upto 42.61% of equity share capital of Sunsure Solarpark to be acquired at a total consideration not exceeding Rs 10.55 crore, to be completed in two tranches, in the capacity as a Captive User.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.25 |
| Dr. Reddys Labs. | 1245.50 |
| Cipla | 1438.75 |
| Zydus Lifesciences | 1150.50 |
| Lupin | 2496.05 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: